Skip to content
healthcare.dev
Get a free key

INZIRQO

NDC 70954-522, hydrochlorothiazide, powder, for suspension, from ANI Pharmaceuticals, Inc..

Product NDC
70954-522
Status
Listed
Labeler
ANI Pharmaceuticals, Inc.
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219141
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70954-522 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDROCHLOROTHIAZIDE10 mg/mL

Pharmacologic classes

Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]

Package NDCNDC-11Package
70954-522-107095405221080 mL in 1 BOTTLE (70954-522-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/41aaea48-6c1b-42c8-a96f-5923d49dc934

  • NADAC price for package 70954052210

    GET /v1/drugs/nadac/70954052210

Use it

Look up 70954-522 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70954-522 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70954-522. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.